Epigenetic therapy in urologic cancers: an update on clinical trials

Epigenetic dysregulation is one of many factors that contribute to cancer development and progression. Numerous epigenetic alterations have been identified in urologic cancers including histone modifications, DNA methylation changes, and microRNA expression. Since these changes are reversible, effor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Faleiro, Inês, Leão, Ricardo, Binnie, Alexandra, de Mello, Ramon Andrade, Maia, Ana-Teresa, Castelo-Branco, Pedro
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355359/
https://ncbi.nlm.nih.gov/pubmed/28036257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14226
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars